{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:48:42Z","timestamp":1783716522391,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.xkme.2021.04.011","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T05:15:25Z","timestamp":1624770925000},"page":"753-761.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Metabolic Acidosis and Cardiovascular Disease in CKD"],"prefix":"10.1016","volume":"3","author":[{"given":"David","family":"Collister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.xkme.2021.04.011_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2021.04.011_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.115.018713","article-title":"Epidemiology and mechanisms of uremia-related cardiovascular disease","volume":"133","author":"Tonelli","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.xkme.2021.04.011_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajcn\/68.3.576","article-title":"Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents","volume":"68","author":"Frassetto","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"10.1016\/j.xkme.2021.04.011_bib4","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00150111","article-title":"Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease","volume":"6","author":"Scialla","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2021.04.011_bib5","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1681\/ASN.2010111181","article-title":"Estimated GFR, albuminuria, and complications of chronic kidney disease","volume":"22","author":"Inker","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2021.04.011_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/j.ajkd.2011.09.021","article-title":"Comparison of concurrent complications of CKD by 2 risk categorization systems","volume":"59","author":"Inker","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2021.04.011_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ki.2012.82","article-title":"Net endogenous acid production is associated with a faster decline in GFR in African Americans","volume":"82","author":"Scialla","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2021.04.011_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.kint.2016.09.012","article-title":"Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes","volume":"91","author":"Scialla","year":"2017","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2021.04.011_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ackd.2017.06.005","article-title":"Adverse effects of the metabolic acidosis of chronic kidney disease","volume":"24","author":"Kraut","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib11","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","article-title":"Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD","volume":"24","author":"Kovesdy","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.xkme.2021.04.011_bib12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2215\/CJN.03730411","article-title":"Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease","volume":"6","author":"Navaneethan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2021.04.011_bib13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/ki.2010.348","article-title":"Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet","volume":"78","author":"Wesson","year":"2010","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib14","doi-asserted-by":"crossref","first-page":"F830","DOI":"10.1152\/ajprenal.00587.2010","article-title":"Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone","volume":"300","author":"Wesson","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1016\/j.xkme.2021.04.011_bib15","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2012.267","article-title":"Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention","volume":"82","author":"Wesson","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib16","article-title":"Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): a report from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"4","author":"Dobre","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.xkme.2021.04.011_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/j.ajkd.2015.03.032","volume":"66","author":"Schutte","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.ajkd.2018.12.023","article-title":"Metabolic acidosis 1 year following kidney transplantation and subsequent cardiovascular events and mortality: an observational cohort study","volume":"73","author":"Djamali","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.xkme.2021.04.011_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ndt\/gfz149","article-title":"Serum bicarbonate and cardiovascular events in hypertensive adults: results from the Systolic Blood Pressure Intervention Trial","volume":"35","author":"Dobre","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2021.04.011_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2021.04.011_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.xkme.2021.04.011_bib22","series-title":"USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2017"},{"key":"10.1016\/j.xkme.2021.04.011_bib23","author":"Tangri"},{"issue":"1","key":"10.1016\/j.xkme.2021.04.011_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12933-016-0462-x","article-title":"Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study","volume":"15","author":"Chubb","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.xkme.2021.04.011_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ejhf.276","article-title":"The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry","volume":"17","author":"Park","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.xkme.2021.04.011_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000454783","article-title":"Serum bicarbonate is associated with heart failure in the multi-ethnic study of atherosclerosis","volume":"45","author":"Kendrick","year":"2017","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2021.04.011_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","article-title":"Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease\u2014a cross-sectional study of predialysis, dialysis and kidney-transplantation patients","volume":"216","author":"Recio-Mayoral","year":"2011","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.xkme.2021.04.011_bib28","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/ndt\/gfr081","article-title":"Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes","volume":"26","author":"Yilmaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2021.04.011_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.114.03311","article-title":"Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"64","author":"Deo","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.xkme.2021.04.011_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/ki.2014.143","article-title":"Endothelin and endothelin antagonists in chronic kidney disease","volume":"86","author":"Kohan","year":"2014","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.xkme.2021.04.011_bib31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2215\/CJN.00380118","article-title":"Effect of treatment of metabolic acidosis on vascular endothelial function in patients with CKD: a pilot randomized cross-over study","volume":"13","author":"Kendrick","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2021.04.011_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.ajkd.2004.09.034","article-title":"Insulin resistance in patients with chronic kidney disease","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2021.04.011_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfq410","article-title":"Metabolic acidosis lowers circulating adiponectin through inhibition of adiponectin gene transcription","volume":"26","author":"Disthabanchong","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.2004090742","article-title":"Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study","volume":"16","author":"Becker","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"16","key":"10.1016\/j.xkme.2021.04.011_bib35","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2016.06.072","article-title":"The Adipokine-Cardiovascular-Lifestyle Network: Translation to clinical practice","volume":"68","author":"Mechanick","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.xkme.2021.04.011_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10741-012-9337-8","article-title":"Direct effects of adipokines on the heart: focus on adiponectin","volume":"18","author":"Park","year":"2013","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10.1016\/j.xkme.2021.04.011_bib37","doi-asserted-by":"crossref","first-page":"C967","DOI":"10.1152\/ajpcell.1990.258.6.C967","article-title":"Effects of changes of pH on the contractile function of cardiac muscle","volume":"258","author":"Orchard","year":"1990","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib38","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/cc11468","article-title":"Mild metabolic acidosis impairs the beta-adrenergic response in isolated human failing myocardium","volume":"16","author":"Schotola","year":"2012","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.xkme.2021.04.011_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000446860","article-title":"Serum bicarbonate and structural and functional cardiac abnormalities in chronic kidney disease\u2014a report from the Chronic Renal Insufficiency Cohort Study","volume":"43","author":"Dobre","year":"2016","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2021.04.011_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ki.5002646","article-title":"Metabolic acidosis inhibits soft tissue calcification in uremic rats","volume":"73","author":"Mendoza","year":"2008","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2021.04.011_bib41","doi-asserted-by":"crossref","first-page":"H1319","DOI":"10.1152\/ajpheart.01362.2007","article-title":"MAPK signaling pathways are needed for survival of H9c2 cardiac myoblasts under extracellular alkalosis","volume":"295","author":"Stathopoulou","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1016\/j.xkme.2021.04.011_bib42","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","article-title":"Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis","volume":"14","author":"Navaneethan","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2021.04.011_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2021.04.011_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2019030287","article-title":"A\u00a0randomized trial comparing the safety, adherence, and pharmacodynamics profiles of two doses of sodium bicarbonate in CKD: the BASE Pilot Trial","volume":"31","author":"Raphael","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2021.04.011_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.07300717","article-title":"Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD","volume":"13","author":"Bushinsky","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10179","key":"10.1016\/j.xkme.2021.04.011_bib46","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(18)32562-5","article-title":"Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial","volume":"393","author":"Wesson","year":"2019","journal-title":"Lancet"},{"issue":"10196","key":"10.1016\/j.xkme.2021.04.011_bib47","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","article-title":"Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension","volume":"394","author":"Wesson","year":"2019","journal-title":"Lancet"},{"issue":"5 Suppl 2","key":"10.1016\/j.xkme.2021.04.011_bib48","first-page":"68","article-title":"How good are the data? USRDS data validation special study","volume":"20","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2021.04.011_bib49","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ki.2014.83","article-title":"Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate","volume":"86","author":"Goraya","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2021.04.011_bib50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2215\/CJN.06190616","article-title":"Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies","volume":"12","author":"Kelly","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2021.04.011_bib51","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1093\/ndt\/gfx087","article-title":"Chronic respiratory disease: an unrecognized risk factor in dialysis","volume":"32","author":"Couchoud","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"22","key":"10.1016\/j.xkme.2021.04.011_bib52","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9784","key":"10.1016\/j.xkme.2021.04.011_bib53","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:21:32Z","timestamp":1762910492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059521001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2590059521001151"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2021.04.011","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Acidosis and Cardiovascular Disease in CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2021.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}